NCT00003993 2015-04-29Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed24 enrolled
NCT00006100 2013-12-18Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1 Unknown
NCT00003408 2013-03-26Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerNational Cancer Institute (NCI)Phase 2 Completed40 enrolled